Table 2.
Variable | 30 Days | 60 Days | 90 Days | 6 Months |
---|---|---|---|---|
No. of deaths | ||||
Overall | 109 | 215 | 281 | 540 |
Surgery | 13 | 20 | 23 | 46 |
5-FU + LV | 76 | 149 | 200 | 393 |
5-FU + LV plus irinotecan | 9 | 16 | 17 | 29 |
5-FU + LV plus oxaliplatin | 11 | 30 | 41 | 72 |
No. of survivors | ||||
Overall | 37,356 | 37,223 | 37,133 | 36,825 |
Surgery | 2,347 | 2,340 | 2,336 | 2,313 |
5-FU + LV | 26,973 | 26,887 | 26,826 | 26,611 |
5-FU + LV plus irinotecan | 2,193 | 2,182 | 2,181 | 2,169 |
5-FU + LV plus oxaliplatin | 5,843 | 5,814 | 5,790 | 5,732 |
Death rate, % | ||||
Overall | 0.29 | 0.57 | 0.75 | 1.4 |
Surgery | 0.55 | 0.85 | 0.98 | 2.0 |
5-FU + LV | 0.28 | 0.55 | 0.74 | 1.5 |
5-FU + LV plus irinotecan | 0.41 | 0.73 | 0.77 | 1.3 |
5-FU + LV plus oxaliplatin | 0.19 | 0.51 | 0.70 | 1.2 |
Abbreviation: 5-FU + LV, fluorouracil plus leucovorin.